Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Heart Failure, Diastolic 1Breast Neoplasms 1

Interventions

Eplerenone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Heart Failure, Diastolic × Eplerenone × Breast × Clear all
NCT01708798 2017-01-05

Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer

University of British Columbia

Phase 2/3 Terminated
44 enrolled
Breast

Breast Neoplasms, Heart Failure, Diastolic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡